OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

NEXT STORY
BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio
PREV STORY
Pulmonary Devices Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type ; Application ; End User, and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ChemioCare Formed to Transform Chemo-Induced Emesis Outcomes Through Patch Technology

NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare”) today announced ...

author_avatar
NASDAQ Market News

Antiulcerant Drugs to Escalate in Emerging Markets to 2022

Technology advances, unhealthy lifestyles propel global marketWELLESLEY, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

Shire plc : Director/PDMR Shareholding

Director/PDMR Shareholding March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...

author_avatar
NASDAQ Market News